Ann LaCasce, MD

    Ann LaCasce, MD

    Director, Dana-Farber/Partners at CancerCare Hematology-Medical Oncology Fellowship Program; Senior Physician; Assistant Professor of Medicine at Harvard Medical School in Boston, Massachusetts
    • 200 Years of Hodgkin Lymphoma Friday, November 15th, 2019

      This year’s ASH Education Program features a look at the progress that has been made in the two centuries since Thomas Hodgkin entered medicine. Here, session chair Ann LaCasce, MD, previews the discussion, including novel therapeutic approaches and their economic impact.

    SHARE